ARTICLE | Clinical News
Synvista preclinical data
October 29, 2007 7:00 AM UTC
In rats, alagebrium reduced serum levels of advanced glycated end-products (AGEs) and restored neuronal nitric oxide synthase ( nNOS) activity, which the company said may reduce diabetes-related gast...